Questions? +1 (202) 335-3939 Login
Trusted News Since 1995
A service for global professionals · Wednesday, December 12, 2018 · 470,858,819 Articles · 3+ Million Readers

The Global Malaria Diagnostics Market (2018-2025) - Increasing Demand for Diagnostic Tools in Malaria Endemic Countries is Driving Growth

/EIN News/ -- Dublin, Nov. 09, 2018 (GLOBE NEWSWIRE) -- The "Malaria Diagnostics Market Size, Share & Trends Analysis Report By Technology (Rapid Diagnostic Tests, Microscopy, Molecular Diagnostic Tests), By Region, Competitive Landscape, And Segment Forecasts, 2018 - 2025" report has been added to ResearchAndMarkets.com's offering.

The global malaria diagnostics market size is expected to reach USD 888.77 million by 2025 expanding at a CAGR of 4.5% during the forecast period.


Rising cases of tropical diseases, developments in diagnostic techniques, and rising investments by local government and private firms are factors propelling the market growth. Malaria is one of the most widespread life-threatening diseases, commonly occurring in the tropical and subtropical regions due to factors such as changing climate, underdeveloped healthcare infrastructure, and lack of advanced treatment options.


Technological advancements in diagnostic testing has been crucial in disease management. Increasing number of government initiatives and R&D investments by market players are anticipated to fuel market potential in the near future. A large number of programs are being undertaken by major companies in order to reduce disease prevalence.


For instance, Novartis Malaria Initiative was aimed at facilitating malaria elimination and control. The company has provided treatment to 750 million people across 60 countries without any profit. Thus, such initiatives are anticipated to facilitate the development of novel technologies and aid in market growth.


Further key findings from the report suggest:

  • Microscopy segment held the largest revenue share in 2017 due to wide usage of microscopic examination for the detection of malarial parasite
  • Rapid Diagnostic Tests (RDTs) would gain a considerable market share in near future owing to ease of use, convenience, and faster diagnosis offered by this technique
  • Molecular diagnostic tests are expected to witness the highest CAGR during the forecast period owing to their highly sensitive nature, accuracy, and capability of detecting low parasite count
  • The Africa region led the global market in 2017 on account of high disease incidence and subsequent adoption of various malarial diagnostic techniques
  • South East Asia held a considerable market share in 2017 owing to high disease reoccurrence and presence of a number of initiatives undertaken for disease control
  • Key companies in the market are Access Bio, Inc.; Alere, Inc.; Premier Medical Corporation Ltd.; Sysmex Partec GmbH; bioMrieux, Inc.; Beckman Coulter, Inc.; Siemens Healthineers; and Leica Microsystems GmbH

Key Topics Covered

Chapter 1 Executive Summary

Chapter 2 Research Methodology
2.1 Country Wise Market: Base Estimates
2.2 Global Market: CAGR Calculation
2.3 Region Based Segment Share Calculation
2.4 Research Scope & Assumptions
2.5 List of Data Sources
2.5.1 Data for primary interviews, by sources
2.5.2 Data for primary interviews, by region
2.6 Market Snapshot

Chapter 3 Malaria Diagnostics Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Increasing demand for diagnostic tools in malaria endemic countries
3.2.2 Development of technologically advanced and efficient diagnostics
3.2.3 Rising investment by government bodies, market players, and private investors to curb prevalence of malaria
3.3 Market Restraint Analysis
3.3.1 Increasing number of countries in malaria elimination phase
3.3.2 Demand for low cost malaria diagnostic tests
3.3.3 Key opportunities prioritized, by technology
3.4 Malaria Diagnostics Market - SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
3.5 Industry Analysis - Porter's
3.6 Malaria Diagnostics Market: Market Position Analysis, 2017

Chapter 4 Malaria Diagnostics Market: Technology Type Estimates & Trend Analysis
4.1 Malaria Diagnostics Market: Technology Type Movement Analysis
4.2 Microscopy
4.2.1 Microscopy market, 2014 - 2025 (USD Million)
4.3 Rapid Diagnostic Tests (RDT)
4.3.1 Rapid Diagnostic Tests (RDT) market, 2014 - 2025 (USD Million)
4.4 Molecular Diagnostic Tests
4.4.1 Molecular Diagnostic Tests market, 2014 - 2025 (USD Million)
4.4.1.1 Conventional PCR market, 2014 - 2025 (USD Million)
4.4.1.2 Real-Time PCR (qPCR or quantitative PCR) market, 2014 - 2025 (USD Million)

Chapter 5 Malaria Diagnostics Market: Regional Estimates & Trend Analysis, by Technology
5.1 Malaria Diagnostics market share by region, 2017 & 2025
5.2 North America
5.2.1 Nigeria
5.2.2 Congo
5.2.3 Uganda
5.3 South East Asia
5.3.1 India
5.3.2 Myanmar
5.3.3 Indonesia
5.4 Eastern Mediterranean
5.4.1 Saudi Arabia
5.4.2 Pakistan
5.5 Western Pacific
5.5.1 China
5.5.2 Papua New Guinea
5.5.3 Cambodia
5.6 Americas
5.6.1 Venezuela
5.6.2 Brazil
5.6.3 Colombia
5.7 Europe
5.7.1 Turkey
5.7.2 France
5.7.3 U.K.
5.7.4 Germany

Chapter 6 Competitive Landscape
6.1 Company Profiles
6.1.1 Access Bio, Inc.
6.1.1.1 Company overview
6.1.1.2 Product benchmarking
6.1.1.3 Strategic initiatives
6.1.2 Abbott
6.1.2.1 Company overview
6.1.2.2 Financial performance
6.1.2.3 Product benchmarking
6.1.2.4 Strategic initiatives
6.1.3 Premier Medical Corporation Ltd.
6.1.3.1 Company overview
6.1.3.2 Product benchmarking
6.1.4 Sysmex Partec GmbH
6.1.4.1 Company overview
6.1.4.2 Financial performance
6.1.4.3 Product benchmarking
6.1.5 bioMerieux
6.1.5.1 Company overview
6.1.5.2 Product benchmarking
6.1.5.3 Strategic initiatives
6.1.6 Beckman Coulter, Inc.
6.1.6.1 Company overview
6.1.6.2 Financial performance
6.1.6.3 Product benchmarking
6.1.6.4 Strategic initiatives
6.1.7 Siemens Healthineers
6.1.7.1 Company overview
6.1.7.2 Financial performance
6.1.7.3 Product benchmarking
6.1.8 Leica Microsystems GmbH
6.1.8.1 Company overview
6.1.8.2 Financial performance
6.1.8.3 Product benchmarking
6.1.8.4 Strategic initiatives
6.1.9 Nikon Corporation
6.1.9.1 Company overview
6.1.9.2 Financial performance
6.1.9.3 Product benchmarking
6.1.9.4 Strategic initiatives
6.1.10 Olympus Corporation
6.1.10.1 Company overview
6.1.10.2 Financial performance
6.1.10.3 Product benchmarking
6.1.10.4 Strategic initiatives
6.1.11 Bio-Rad Laboratories, Inc.
6.1.11.1 Company overview
6.1.11.2 Financial performance
6.1.11.3 Product benchmarking

For more information about this report visit https://www.researchandmarkets.com/research/b4vrns/the_global?w=12

                    CONTACT: ResearchAndMarkets.com
                             Laura Wood, Senior Press Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                    Related Topics: Infectious Disease Testing
                    

22157.jpg

Powered by EIN News


EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.

Submit your press release